Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Vincent F. La Russa"'
Autor:
Carlos Gabriel Belloc, Leandro Feldman, Valeria Beatriz Fernández Vallone, Alba Elizabeth Honegger, Raul H. Bordenave, Vivian Labovsky, Vincent F. La Russa, Eduardo Bullorsky, Huei Chi Wen, Norma Alejandra Chasseing, Erica Leonor Hofer
Publikováno v:
Stem Cells and Development. 19:359-370
We have shown that bone marrow (BM) from untreated advanced lung and breast cancer patients (LCP and BCP) have a reduced number of colony-forming unit fibroblasts (CFU-Fs) or mesenchymal stem cells (MSCs). Factors that regulate the proliferation and
Autor:
Vincent F. La Russa, Sherrie Price, Hana Safah, Marilyn M. Li, Guanchao Jiang, Fan Yang, K. C. Kim, Melanie Ehrlich, Karen Weissbecker
Publikováno v:
Cancer Biology & Therapy. 2:104-109
Very promising results have been obtained in clinical trials on chronic-phase chronic myeloid leukemia (CP-CML) patients treated with imatinib mesylate (IM; Gleevecr, STI571), a BCR-ABL tyrosine kinase inhibitor. However, we found that IM caused cons
Autor:
Hana Safah, M.D Alan Miller Ph.D., Vincent F. La Russa, Debasis Mondal, Tyler Curiel, M.D Marta Rozans Ph.D., Roy Weiner, Krishna C. Agrawal
Publikováno v:
Cancer Investigation. 21:792-804
Recent studies have suggested that stem cells are able to cross primordial tissue barriers. Their ability to respond to unrelated microenvironmental signals strongly suggest that they have greater potential than previously imagined especially for the
Autor:
Jakob Reiser, Lili Bao, Vincent F. La Russa, Xian Yang Zhang, Jay K. Kolls, Paul Schwarzenberger
Publikováno v:
Molecular Therapy. 5(5):555-565
Bone marrow–derived mesenchymal stromal cells (MSCs) have attracted attention as potential platforms for the systemic delivery of therapeutic proteins in vivo following gene transfer using oncogenic retroviruses. However, the major limitations of t
Publikováno v:
Cancer Investigation. 20:124-138
In the broadest sense, stem cells are primitive cells endowed with extensive capacities to develop and differentiate into functional and mature tissues or organs. A small, self-maintaining sub-popu...
Autor:
Bruce L. Innis, Vincent F. La Russa
Publikováno v:
Baillière's Clinical Haematology. 8:249-270
Infection with many flaviviruses is associated with transient suppression of haematopoiesis. Of the flaviviruses of man, none are more accessible to clinical and laboratory study than dengue. Consequently, the clinical syndrome of dengue-associated b
Publikováno v:
Stem cells (Dayton, Ohio). 24(6)
Interleukin-17A (IL-17A) is a proinflammatory cytokine expressed in activated T-cells. It is required for microbial host defense and is a potent stimulator of granulopoiesis. In a dose-dependent fashion, IL-17A expanded human mesenchymal stem cells (
Autor:
Jakob Reiser, Leena Pradhan, Charles S. Hemenway, Xian Yang Zhang, Debasis Mondal, Vincent F. La Russa
The intriguing biology of stem cells and their vast clinical potential is emerging rapidly for gene therapy. Bone marrow stem cells, including the pluripotent haematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs) and possibly the multipoten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d3ef45d637a27cc32d31dba9894d90c
https://europepmc.org/articles/PMC1371057/
https://europepmc.org/articles/PMC1371057/
Autor:
Raul H. Bordenave, Vincent F. La Russa, Erica Leonor Hofer, Norma Alejandra Chasseing, Eduardo Bullorsky, Alba Elizabeth Honegger
Previously, we reported a deficient cloning capacity of the bone marrow (BM) mesenchymal stem cells to give colony-forming unit fibroblast (CFU-F) and an inefficient confluence capacity of BM stromal cells in advanced untreated lung cancer patients (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47bc18c99c7cce23cb443a673027205e
http://online.liebertpub.com/doi/pdfplus/10.1089/scd.2005.14.587
http://online.liebertpub.com/doi/pdfplus/10.1089/scd.2005.14.587
Bone-marrow-derived mesenchymal stem cells (MSCs) have attracted considerable attention as tools for the systemic delivery of therapeutic proteins in vivo, and the ability to efficiently transfer genes of interest into such cells would create a numbe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebc18b5bdaa5ede1b7fb65b679fadac3
https://europepmc.org/articles/PMC321376/
https://europepmc.org/articles/PMC321376/